Search results
Results from the WOW.Com Content Network
Recurrent prostate cancer; Clinical Information. A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40.
C61 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of prostate. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. This code is applicable to male patients only.
A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40.
Browse all the diagnosis codes used for malignant neoplasm of prostate (c61). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range.
ICD-10 code C61 for Malignant neoplasm of prostate is a medical classification as listed by WHO under the range - Malignant neoplasms . Official Long Descriptor. Malignant neoplasm of prostate. Use additional code, if applicable, to identify: hormone sensitivity status (Z19.1 - Z19.2)
C61 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of prostate. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 .
The ICD code C61 is used to code Prostate cancer. Prostate cancer, also known as carcinoma of the prostate, is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively quickly.
ICD-10-CM Diagnosis Codes. C61 - Malignant neoplasm of prostate. The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products: Find-A-Code Essentials. Find-A-Code Professional.
C80.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM C80.1 became effective on October 1, 2023. This is the American ICD-10-CM version of C80.1 - other international versions of ICD-10 C80.1 may differ.
code, if applicable, to identify: hormone sensitivity status (Z19.1-Z19.2) rising PSA following treatment for malignant neoplasm of prostate